They are mesenchymal neoplasms expressing KIT(CD117) tyrosine kinase and showing presence of activating mutations in KIT or PDGFRα (platelet-derived growth factor alpha) [2]. The gene discussed is PDGFRA; the disease is mesenchymal cell neoplasm.